Literature DB >> 12562462

A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function.

S A Sonwalkar1, I B Holbrook, I Phillips, S M Kelly.   

Abstract

BACKGROUND: The assessment of exocrine pancreatic insufficiency is part of the routine work-up of patients with persistent diarrhoea or suspected steatorrhoea. Direct and indirect tests for the diagnosis of exocrine pancreatic insufficiency have their drawbacks. Measurement of faecal elastase 1 by enzyme-linked immunoabsorbent assay is a simple, non-invasive, robust test for exocrine pancreatic insufficiency.
METHODS: We performed a prospective comparison of the para-aminobenzoic acid test and faecal elastase 1 test in 45 patients being investigated for diarrhoea or suspected steatorrhoea. Details of clinical suspicion, imaging and response to treatment were recorded.
RESULTS: Exocrine pancreatic function was normal in 20 patients with normal para-aminobenzoic acid and faecal elastase 1 levels. Eight patients had exocrine pancreatic insufficiency with low para-aminobenzoic acid and faecal elastase 1 levels, which improved with enzyme supplementation. In 14 of the 15 patients with low or borderline low para-aminobenzoic acid and normal faecal elastase 1 levels, a non-pancreatic cause was found; one patient had a false positive para-aminobenzoic acid test. Two had normal para-aminobenzoic acid but low faecal elastase 1 levels. One improved with pancreatic supplementation, and imaging revealed chronic pancreatitis. The other had a false positive faecal elastase 1 test related to profuse diarrhoea.
CONCLUSIONS: Faecal elastase 1 estimation is a simple, non-invasive, robust test of exocrine pancreatic insufficiency, performed on an out-patient stool sample. Its diagnostic performance is superior to that of the para-aminobenzoic acid test in investigating patients with diarrhoea or suspected steatorrhoea.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562462     DOI: 10.1046/j.1365-2036.2003.01451.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation?

Authors:  Kate E Evans; John S Leeds; Stephen Morley; David S Sanders
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

2.  Fecal elastase: a useful test for pancreatic insufficiency?

Authors:  Jo Tod; David Fine
Journal:  Dig Dis Sci       Date:  2010-10       Impact factor: 3.199

3.  Now that fecal elastase is available in the United States, should clinicians start using it?

Authors:  Paul G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2004-04

4.  Using faecal elastase-1 to screen for chronic pancreatitis in patients admitted with acute pancreatitis.

Authors:  R C Turner; R McDermott
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 5.  Less common etiologies of exocrine pancreatic insufficiency.

Authors:  Vikesh K Singh; Mark E Haupt; David E Geller; Jerry A Hall; Pedro M Quintana Diez
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

6.  Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition.

Authors:  Ramesh P Arasaradnam; Steven Brown; Alastair Forbes; Mark R Fox; Pali Hungin; Lawrence Kelman; Giles Major; Michelle O'Connor; Dave S Sanders; Rakesh Sinha; Stephen Charles Smith; Paul Thomas; Julian R F Walters
Journal:  Gut       Date:  2018-04-13       Impact factor: 23.059

7.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.